🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yusuke Shibuya

Tohoku University Hospital

ORCID: 0000-0001-9295-4108

PsychologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer”.

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

Research Square(2023)10.21203/rs.3.rs-3399502/v1

N/A

0DataRank · unranked

1 citations

Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S. Harrington, Soumya Korrapati +6 more

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

Cancer Gene Therapy(2024)10.1038/s41417-024-00748-w

N/A

0DataRank · unranked

11 citations

Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S. Harrington, Soumya Korrapati, Yusuke Shibuya +6 more

Targeting Metabolic Vulnerability by Combining NAMPT Inhibitors and Disulfiram for Treatment of Recurrent Ovarian Cancer

Research Square(2024)10.21203/rs.3.rs-4150814/v1

N/A

0DataRank · unranked

0 citations

Kei Kudo, Daniel R. Crooks, Yoshimi Endo Greer, Ye Yang, Jeffrey Brender +10 more

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

Cell Death and Disease(2025)10.1038/s41419-025-07672-3

N/A

0DataRank · unranked

4 citations

Yoshimi Endo Greer, Daniel R. Crooks, Ye Yang, Jeffrey Brender, Teruhiko Yoshida +10 more